financetom
Business
financetom
/
Business
/
D.R. Horton Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
D.R. Horton Unusual Options Activity
Oct 15, 2024 9:36 AM

Investors with significant funds have taken a bearish position in D.R. Horton ( DHI ) , a development that retail traders should be aware of.

This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in DHI usually indicates foreknowledge of upcoming events.

Today, Benzinga's options scanner identified 10 options transactions for D.R. Horton ( DHI ). This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 20% being bullish and 50% bearish. Of all the options we discovered, 9 are puts, valued at $283,812, and there was a single call, worth $48,990.

What's The Price Target?

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $185.0 and $195.0 for D.R. Horton ( DHI ), spanning the last three months.

Volume & Open Interest Trends

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for D.R. Horton's ( DHI ) options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of D.R. Horton's ( DHI ) whale trades within a strike price range from $185.0 to $195.0 in the last 30 days.

D.R. Horton Call and Put Volume: 30-Day Overview

Significant Options Trades Detected:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
DHI CALL TRADE BEARISH 10/25/24 $7.4 $6.9 $6.9 $185.00 $48.9K 90 75
DHI PUT TRADE NEUTRAL 11/15/24 $10.5 $10.2 $10.37 $195.00 $41.4K 224 5
DHI PUT SWEEP BEARISH 01/17/25 $13.7 $13.4 $13.8 $195.00 $37.2K 206 45
DHI PUT SWEEP BEARISH 11/15/24 $10.5 $10.2 $10.38 $195.00 $36.7K 224 80
DHI PUT SWEEP BEARISH 01/17/25 $13.9 $13.4 $13.68 $195.00 $30.4K 206 67

About D.R. Horton

D.R. Horton ( DHI ) is a leading homebuilder in the United States with operations in 118 markets across 33 states. D.R. Horton ( DHI ) mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's ( DHI ) headquarters are in Arlington, Texas, and it manages six regional segments across the United States.

Having examined the options trading patterns of D.R. Horton ( DHI ), our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Where Is D.R. Horton Standing Right Now?

With a trading volume of 763,432, the price of DHI is up by 2.42%, reaching $191.63.

Current RSI values indicate that the stock is is currently neutral between overbought and oversold.

Next earnings report is scheduled for 14 days from now.

Expert Opinions on D.R. Horton

1 market experts have recently issued ratings for this stock, with a consensus target price of $215.0.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.

* An analyst from B of A Securities has decided to maintain their Buy rating on D.R. Horton ( DHI ), which currently sits at a price target of $215.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for D.R. Horton ( DHI ), Benzinga Pro gives you real-time options trades alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson Insider Sold Shares Worth $930,113, According to a Recent SEC Filing
Johnson & Johnson Insider Sold Shares Worth $930,113, According to a Recent SEC Filing
Sep 4, 2024
04:51 PM EDT, 09/03/2024 (MT Newswires) -- Robert J Decker, Vice President, Corporate Controller, on August 30, 2024, sold 5,635 shares in Johnson & Johnson ( JNJ ) for $930,113. Following the Form 4 filing with the SEC, Decker has control over a total of 19,721 shares of the company, with 18,973 shares held directly and 748 controlled indirectly. SEC...
Transocean Gets $123 Million Drillship Contract in India
Transocean Gets $123 Million Drillship Contract in India
Sep 4, 2024
10:42 AM EDT, 09/04/2024 (MT Newswires) -- Transocean ( RIG ) said Wednesday that it secured an ultra-deepwater drillship contract from Reliance Industries for the Dhirubhai Deepwater KG1 project, covering six wells offshore India. The 300-day program is slated to start in Q2 2026 and is expected to contribute about $123 million in backlog, excluding additional services and a mobilization...
Illumina Files Mixed Securities Shelf
Illumina Files Mixed Securities Shelf
Sep 4, 2024
10:41 AM EDT, 09/04/2024 (MT Newswires) -- Illumina ( ILMN ) filed an automatic shelf registration statement with the US Securities and Exchange Commission Wednesday covering the potential sale of securities from time to time in one or more offerings. The statement covers debt securities, common and preferred shares, warrants, stock purchase contracts, stock purchase units, and subscription rights. The...
Athira Pharma Alzheimer's Treatment Candidate Fails to Meet Targets -- Shares Sink After Hours
Athira Pharma Alzheimer's Treatment Candidate Fails to Meet Targets -- Shares Sink After Hours
Sep 4, 2024
04:50 PM EDT, 09/03/2024 (MT Newswires) -- Athira Pharma ( ATHA ) said late Tuesday that topline results from its phase 2/3 trial of fosgonimeton in patients with mild-to-moderate Alzheimer's disease failed to reach primary and main secondary endpoints. Company shares plunged nearly 72% in after-hours activity. In pre-specified subgroups characterized by more rapid disease progression, the group treated with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved